Endocrine-Related Cancer

Papers
(The H4-Index of Endocrine-Related Cancer is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Survival following resection of 10,244 lung neuroendocrine tumours: a population study110
Refining long-term surveillance requirements in patients with differentiated thyroid cancer66
Acknowledgement to reviewers62
Chemokines with CXC motif and their receptors in neuroendocrine neoplasms56
Metastatic neuroendocrine neoplasms of the breast: a systematic review54
Radiation reprograms fibroblasts to drive prostate cancer therapy resistance40
Update on the genetics of paragangliomas39
ERRATUM: Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs36
Clinical presentation of bone metastases in neuroendocrine tumors: a retrospective cohort study34
ERRATUM: Roles of the HOXA10 gene during castrate-resistant prostate cancer progression34
Identifying metastatic renal cell carcinoma in thyroid fine-needle aspirates by molecular testing31
NP-101 in Combination with Nivolumab and Ipilimumab in Metastatic Extra-pulmonary Neuroendocrine Carcinomas (EP-NECs): A Pilot Study31
Сytotoxic T lymphocyte-associated protein 4 (CTLA4) is overexpressed in a subset of prolactin- and growth hormone-secreting pituitary adenomas31
Deregulated kinase action in prostate cancer: molecular basis and therapeutic implications29
Targeting growth hormone in cancer: future perspectives29
Interleukin-6 promotes the dedifferentiation of papillary thyroid cancer cells27
Defining aging-associated factors that increase susceptibility to prostate cancer27
Prognostic of recurrence and survival in poorly differentiated thyroid cancer26
Metabolically active brown adipose tissue in PPGL: an observational cohort study24
The genetic changes in 11p15.5-related pheochromocytomas and paragangliomas23
Differential activity of specific inhibitors of transcription regulating cyclin-dependent kinases in thyroid cancer cells23
CORRIGENDUM: GPER1 is regulated by insulin in cancer cells and cancer-associated fibroblasts21
PRRT for well-differentiated gastroenteropancreatic neuroendocrine tumors (GEP-NETs)21
0.092833042144775